Marker Therapeutics, Inc. (MRKR)
1.40
-0.02
(-1.41%)
USD |
NASDAQ |
May 18, 16:00
1.40
0.00 (0.00%)
After-Hours: 20:00
Marker Therapeutics Research and Development Expense (Quarterly) : 2.843M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Tenaya Therapeutics, Inc. | 14.84M |
| Krystal Biotech, Inc. | 13.81M |
| Neurocrine Biosciences, Inc. | 296.20M |
| Agenus, Inc. | 11.82M |
| Curis, Inc. | 6.449M |